Review



t5 caption a7 active substance  (Gilead Sciences)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 97
      Buy from Supplier

    Structured Review

    Gilead Sciences t5 caption a7 active substance
    T5 Caption A7 Active Substance, supplied by Gilead Sciences, used in various techniques. Bioz Stars score: 97/100, based on 894 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/t5+caption+a7+active+substance/Sovaldi/pmc06728536-192-20-34
    Average 97 stars, based on 894 article reviews
    t5 caption a7 active substance - by Bioz Stars, 2026-10
    97/100 stars

    Images

    Related Articles

    Transplantation Assay:

    Article Title: New Direct-Acting Antivirals for the Treatment of Patients With Hepatitis C Virus Infection: A Systematic Review of Randomized Controlled Trials
    Article Snippet: .. Two combination regimens (velpatasvir/sofosbuvir and asunaprevir/daclatasvir/beclabuvir) are used to treat genotypes 5 and 6 ( ). table ft1 table-wrap mode="anchored" t5 caption a7 Active substance (commercial name) Year of approval Dosage Administration Genotype Sofosbuvir (Sovaldi) 2014 400 mg 12 wks (SOF + PegIFN/RBV) 1, 2, 3, and 4 12 wks (SOF + RBV) 24 wks (SOF + RBV) Until the transplantation 24 wks (SOF + RBV) Until the transplantation 48 wks (SOF + RBV) 12 wks (SOF + SIM + RBV) 24 wks (SOF + SIM + RBV) Simeprevir (Olysio) 2015 150 mg 12 wks (SIM + PegIFN/RBV) + 12 wks (PegIFN/RBV) 1 and 4 12 wks (SIM + PegIFN/RBV) + 36 wks (PegIFN/RBV) 12 wks (SIM + SOF) 12 wks (SIM + SOF) + 12 wks (SIM + SOF) Daclatasvir (Daklinza) 2015 60 mg 12 wks (DACL + SOF ± RBV) 1, 3, and 4 24 wks (DACL + SOF ± RBV) 24 wks (DACL + PegIFN + RBV) + 24 wks (PegIFN/RBV) Ledipasvir/sofosbuvir (Harvoni) 2014 90 mg/400 mg 8 wks (Led/SOF) 1,3, and 4 12 wks (Led/SOF ± RBV) 24 wks (Led/SOF ± RBV) Ombitasvir/paritaprevir/ritonavir (Viekirax) 2015 12.5 mg/75 mg/250 mg 12 wks (ombitasvir/paritaprevir/ritonavir + RBV) 1 and 4 24 wks (ombitasvir/paritaprevir/ritonavir + RBV) Dasabuvir (Exviera) 2015 50 mg 12 wks (ombitasvir/paritaprevir/ritonavir + DAS) 1 and 4 24 wks (ombitasvir/paritaprevir/ritonavir + DAS) 12 wks (ombitasvir/paritaprevir/ritonavir + DAS + RBV) 24 wks (ombitasvir/paritaprevir/ritonavir + DAS + RBV) Grazoprevir/elbasvir (Zepatier) 2016 100 mg/50 mg 8 wks (GRA + ELB) 1 and 4 12 wks (GRA + ELB ± RBV) Velpatasvir/sofosbuvir (Epclusa) 2016 100 mg/400 mg 12 wks (Valp + SOF ± RBV) 1, 2, 3, 4, 5, and 6 Asunaprevir/daclatasvir/beclabuvir Soon be available 1, 2, 3, 4, and 5 Open in a separate window Wks, weeks; SOF, sofosbuvir; RBV, ribavirin; IFN, interferon; SIM, simeprevir; DACL, daclatasvir; Led, ledipasvir; DAS, dasabuvir; GRA, grazoprevir; ELB, elbasvir; Valp, velpatasvir. a Faldaprevir 120 mg was withdrawn during the marketing authorization procedure. ..



    Similar Products

    t5 caption a7 active substance  (Gilead Sciences)
    97
    Gilead Sciences t5 caption a7 active substance
    T5 Caption A7 Active Substance, supplied by Gilead Sciences, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/t5+caption+a7+active+substance/Sovaldi/pmc06728536-192-20-34
    Average 97 stars, based on 1 article reviews
    t5 caption a7 active substance - by Bioz Stars, 2026-10
    97/100 stars
    		  Buy from Supplier

    Image Search Results